How would a latent period for early breast cancer affect the benefit of screening?
Theoretical Medicine and Bioethics 2 (2):169-182 (1987)
| Abstract | The ideal goal of a screening program for breast cancer is to detect the disease at a stage when it is still curable by a simple lumpectomy. This goal would be possible if the tumor had an early latent period before it was vascularized. However, even if there existed a harmless screening examination that was sensitive enough to discover the cancer at this stage the benefit to be gained from a screening program would be highly dependent on the time the tumor spends in the latent stage as well as on the chance of false negatives at the examination. Calculations derived from a mathematical model suggest a variety of theoretically possible situations including: (1) For certain cancers screening every three years would offer almost as much benefit as screening every year; (2) A large increase in the sensitivity of a screening examination does not necessarily lead to a large increase in the benefit of a screening program; (3) For certain cancers the benefit of screening might remain low no matter how sensitive the examination used. | |||||||||
| Keywords | No keywords specified (fix it) | |||||||||
| Categories | ||||||||||
| Options |
|
|||||||||
Download options| PhilPapers Archive |
Upload a copy of this paper Check publisher's policy on self-archival Papers currently archived: 5,709 |
| External links |
 |
| Through your library | Configure |
Similar books and articlesD. Miller (1996). Parliament and Screening: Ethical and Social Problems Arising From Testing and Screening for HIV and Genetic Disease. Journal of Medical Ethics 22 (6):366-366.
Christopher Read Hitchcock (1997). Discussion: Screening-Off and Visibility to Selection. Biology and Philosophy 12 (4).
Ayodele S. Jegede (2009). Culture and Genetic Screening in Africa. Developing World Bioethics 9 (3):128-137.
Victoria Seavilleklein (2009). Challenging the Rhetoric of Choice in Prenatal Screening. Bioethics 23 (1):68-77.
Ingrid Burger & Nancy Kass (2009). Screening in the Dark: Ethical Considerations of Providing Screening Tests to Individuals When Evidence is Insufficient to Support Screening Populations. American Journal of Bioethics 9 (4):3-14.
Diane B. Paul (1994). Toward a Realistic Assessment of PKU Screening. PSA: Proceedings of the Biennial Meeting of the Philosophy of Science Association 1994:322 - 328.
Sahin Aksoy (2001). Antenatal Screening and its Possible Meaning From Unborn Baby's Perspective. BMC Medical Ethics 2 (1):1-11.
Stewart Justman (2012). Uninformed Consent: Mass Screening for Prostate Cancer. Bioethics 26 (3):143-148.
Lisa S. Parker (1995). Breast Cancer Genetic Screening and Critical Bioethics' Gaze. Journal of Medicine and Philosophy 20 (3):313-337.
Analytics
Monthly downloads
Sorry, there are not enough data points to plot this chart.
|
Added to index2009-01-28Total downloads1 ( #275,053 of 549,699 )Recent downloads (6 months)0How can I increase my downloads? |
My notes
Discussion
